GO:0015630 | microtubule cytoskeleton | 10.0% (14/140) | 7.53 | 0.0 | 0.0 |
GO:0008017 | microtubule binding | 14.29% (20/140) | 5.42 | 0.0 | 0.0 |
GO:0005856 | cytoskeleton | 12.14% (17/140) | 6.14 | 0.0 | 0.0 |
GO:0015631 | tubulin binding | 14.29% (20/140) | 5.33 | 0.0 | 0.0 |
GO:0008092 | cytoskeletal protein binding | 15.0% (21/140) | 4.65 | 0.0 | 0.0 |
GO:0007018 | microtubule-based movement | 10.0% (14/140) | 6.06 | 0.0 | 0.0 |
GO:0003777 | microtubule motor activity | 10.0% (14/140) | 6.0 | 0.0 | 0.0 |
GO:0003774 | cytoskeletal motor activity | 10.0% (14/140) | 5.56 | 0.0 | 0.0 |
GO:0007017 | microtubule-based process | 11.43% (16/140) | 4.86 | 0.0 | 0.0 |
GO:0003985 | acetyl-CoA C-acetyltransferase activity | 4.29% (6/140) | 9.75 | 0.0 | 0.0 |
GO:0016453 | C-acetyltransferase activity | 4.29% (6/140) | 9.75 | 0.0 | 0.0 |
GO:0003988 | acetyl-CoA C-acyltransferase activity | 4.29% (6/140) | 8.87 | 0.0 | 0.0 |
GO:0016408 | C-acyltransferase activity | 4.29% (6/140) | 8.21 | 0.0 | 0.0 |
GO:0043228 | non-membrane-bounded organelle | 12.14% (17/140) | 3.28 | 0.0 | 0.0 |
GO:0043232 | intracellular non-membrane-bounded organelle | 12.14% (17/140) | 3.28 | 0.0 | 0.0 |
GO:0006635 | fatty acid beta-oxidation | 4.29% (6/140) | 5.86 | 0.0 | 0.0 |
GO:0019395 | fatty acid oxidation | 4.29% (6/140) | 5.81 | 0.0 | 0.0 |
GO:0009062 | fatty acid catabolic process | 4.29% (6/140) | 5.64 | 0.0 | 0.0 |
GO:0072329 | monocarboxylic acid catabolic process | 4.29% (6/140) | 5.35 | 0.0 | 0.0 |
GO:0034440 | lipid oxidation | 4.29% (6/140) | 5.23 | 0.0 | 0.0 |
GO:0140657 | ATP-dependent activity | 10.71% (15/140) | 2.63 | 0.0 | 0.0 |
GO:0005096 | GTPase activator activity | 4.29% (6/140) | 5.01 | 0.0 | 1e-06 |
GO:0030865 | cortical cytoskeleton organization | 2.86% (4/140) | 6.82 | 0.0 | 1e-06 |
GO:0042995 | cell projection | 2.14% (3/140) | 8.1 | 0.0 | 3e-06 |
GO:0000166 | nucleotide binding | 20.71% (29/140) | 1.51 | 0.0 | 3e-06 |
GO:1901265 | nucleoside phosphate binding | 20.71% (29/140) | 1.51 | 0.0 | 3e-06 |
GO:0043168 | anion binding | 20.71% (29/140) | 1.49 | 0.0 | 4e-06 |
GO:1901363 | heterocyclic compound binding | 20.71% (29/140) | 1.47 | 0.0 | 5e-06 |
GO:0044242 | cellular lipid catabolic process | 4.29% (6/140) | 4.37 | 1e-06 | 6e-06 |
GO:0030695 | GTPase regulator activity | 4.29% (6/140) | 4.37 | 1e-06 | 6e-06 |
GO:0060589 | nucleoside-triphosphatase regulator activity | 4.29% (6/140) | 4.37 | 1e-06 | 6e-06 |
GO:0036094 | small molecule binding | 20.71% (29/140) | 1.46 | 1e-06 | 6e-06 |
GO:0008360 | regulation of cell shape | 2.14% (3/140) | 7.54 | 1e-06 | 6e-06 |
GO:0032970 | regulation of actin filament-based process | 2.86% (4/140) | 5.96 | 1e-06 | 6e-06 |
GO:0016407 | acetyltransferase activity | 4.29% (6/140) | 4.32 | 1e-06 | 6e-06 |
GO:0030258 | lipid modification | 4.29% (6/140) | 4.33 | 1e-06 | 6e-06 |
GO:0016042 | lipid catabolic process | 4.29% (6/140) | 4.32 | 1e-06 | 6e-06 |
GO:0007165 | signal transduction | 8.57% (12/140) | 2.58 | 1e-06 | 8e-06 |
GO:0035639 | purine ribonucleoside triphosphate binding | 16.43% (23/140) | 1.63 | 1e-06 | 1.1e-05 |
GO:0008047 | enzyme activator activity | 4.29% (6/140) | 4.1 | 2e-06 | 1.3e-05 |
GO:0046395 | carboxylic acid catabolic process | 4.29% (6/140) | 4.0 | 2e-06 | 1.8e-05 |
GO:0016054 | organic acid catabolic process | 4.29% (6/140) | 4.0 | 2e-06 | 1.8e-05 |
GO:0140677 | molecular function activator activity | 4.29% (6/140) | 4.01 | 2e-06 | 1.8e-05 |
GO:0022604 | regulation of cell morphogenesis | 2.14% (3/140) | 6.73 | 3e-06 | 2.4e-05 |
GO:0007163 | establishment or maintenance of cell polarity | 2.14% (3/140) | 6.65 | 4e-06 | 2.8e-05 |
GO:0006631 | fatty acid metabolic process | 4.29% (6/140) | 3.88 | 4e-06 | 2.8e-05 |
GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 5.0% (7/140) | 3.43 | 5e-06 | 3.1e-05 |
GO:0005515 | protein binding | 19.29% (27/140) | 1.36 | 5e-06 | 3.2e-05 |
GO:0009987 | cellular process | 34.29% (48/140) | 0.9 | 6e-06 | 3.7e-05 |
GO:0005874 | microtubule | 3.57% (5/140) | 4.26 | 8e-06 | 4.6e-05 |
GO:0022603 | regulation of anatomical structure morphogenesis | 2.14% (3/140) | 6.31 | 8e-06 | 5e-05 |
GO:0019901 | protein kinase binding | 2.14% (3/140) | 6.24 | 1e-05 | 5.7e-05 |
GO:0007010 | cytoskeleton organization | 4.29% (6/140) | 3.65 | 1e-05 | 5.8e-05 |
GO:0099081 | supramolecular polymer | 3.57% (5/140) | 4.13 | 1.2e-05 | 6.3e-05 |
GO:0099512 | supramolecular fiber | 3.57% (5/140) | 4.13 | 1.2e-05 | 6.3e-05 |
GO:0007264 | small GTPase mediated signal transduction | 2.14% (3/140) | 6.14 | 1.2e-05 | 6.4e-05 |
GO:0099513 | polymeric cytoskeletal fiber | 3.57% (5/140) | 4.14 | 1.1e-05 | 6.4e-05 |
GO:0044282 | small molecule catabolic process | 4.29% (6/140) | 3.53 | 1.6e-05 | 8.3e-05 |
GO:0043226 | organelle | 19.29% (27/140) | 1.24 | 2.3e-05 | 0.000116 |
GO:0032553 | ribonucleotide binding | 17.14% (24/140) | 1.35 | 2.2e-05 | 0.000116 |
GO:0043229 | intracellular organelle | 19.29% (27/140) | 1.24 | 2.3e-05 | 0.000118 |
GO:0097367 | carbohydrate derivative binding | 17.14% (24/140) | 1.34 | 2.5e-05 | 0.000125 |
GO:0050660 | flavin adenine dinucleotide binding | 3.57% (5/140) | 3.76 | 3.9e-05 | 0.000188 |
GO:0032956 | regulation of actin cytoskeleton organization | 2.14% (3/140) | 5.57 | 3.9e-05 | 0.00019 |
GO:0019900 | kinase binding | 2.14% (3/140) | 5.42 | 5.2e-05 | 0.000247 |
GO:0032555 | purine ribonucleotide binding | 16.43% (23/140) | 1.3 | 5.8e-05 | 0.000267 |
GO:0005524 | ATP binding | 13.57% (19/140) | 1.46 | 6.3e-05 | 0.000289 |
GO:0003674 | molecular_function | 51.43% (72/140) | 0.54 | 7.1e-05 | 0.000319 |
GO:0043167 | ion binding | 21.43% (30/140) | 1.06 | 8.2e-05 | 0.000362 |
GO:0017076 | purine nucleotide binding | 16.43% (23/140) | 1.24 | 0.000102 | 0.000447 |
GO:0051493 | regulation of cytoskeleton organization | 2.14% (3/140) | 5.07 | 0.000108 | 0.000464 |
GO:0099080 | supramolecular complex | 3.57% (5/140) | 3.4 | 0.000126 | 0.000537 |
GO:0030234 | enzyme regulator activity | 4.29% (6/140) | 2.86 | 0.000204 | 0.000857 |
GO:0032787 | monocarboxylic acid metabolic process | 4.29% (6/140) | 2.85 | 0.00021 | 0.000869 |
GO:0005488 | binding | 35.71% (50/140) | 0.66 | 0.000282 | 0.001152 |
GO:0098772 | molecular function regulator activity | 4.29% (6/140) | 2.76 | 0.000287 | 0.001156 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4.29% (6/140) | 2.68 | 0.000392 | 0.001558 |
GO:0050793 | regulation of developmental process | 2.14% (3/140) | 4.42 | 0.000402 | 0.001578 |
GO:0110165 | cellular anatomical entity | 29.29% (41/140) | 0.73 | 0.000508 | 0.001967 |
GO:0097159 | organic cyclic compound binding | 25.0% (35/140) | 0.8 | 0.000615 | 0.002354 |
GO:0005739 | mitochondrion | 4.29% (6/140) | 2.55 | 0.000632 | 0.002358 |
GO:0003955 | NAD(P)H dehydrogenase (quinone) activity | 1.43% (2/140) | 5.79 | 0.000628 | 0.002374 |
GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 1.43% (2/140) | 5.45 | 0.001 | 0.003686 |
GO:0050789 | regulation of biological process | 12.14% (17/140) | 1.2 | 0.00124 | 0.004517 |
GO:0031410 | cytoplasmic vesicle | 2.86% (4/140) | 3.11 | 0.001298 | 0.004617 |
GO:0097708 | intracellular vesicle | 2.86% (4/140) | 3.11 | 0.001298 | 0.004617 |
GO:0032559 | adenyl ribonucleotide binding | 13.57% (19/140) | 1.1 | 0.001381 | 0.004858 |
GO:0019899 | enzyme binding | 2.86% (4/140) | 3.06 | 0.001469 | 0.005107 |
GO:0003924 | GTPase activity | 2.86% (4/140) | 3.04 | 0.001521 | 0.005229 |
GO:0005525 | GTP binding | 2.86% (4/140) | 2.98 | 0.00177 | 0.005951 |
GO:0032561 | guanyl ribonucleotide binding | 2.86% (4/140) | 2.98 | 0.00177 | 0.005951 |
GO:0050794 | regulation of cellular process | 11.43% (16/140) | 1.18 | 0.001941 | 0.006457 |
GO:0019001 | guanyl nucleotide binding | 2.86% (4/140) | 2.94 | 0.001971 | 0.006487 |
GO:0030554 | adenyl nucleotide binding | 13.57% (19/140) | 1.05 | 0.002145 | 0.006984 |
GO:0042147 | retrograde transport, endosome to Golgi | 1.43% (2/140) | 4.81 | 0.002385 | 0.007683 |
GO:0031982 | vesicle | 2.86% (4/140) | 2.85 | 0.002488 | 0.007931 |
GO:0033043 | regulation of organelle organization | 2.14% (3/140) | 3.49 | 0.002556 | 0.008062 |
GO:0065007 | biological regulation | 12.14% (17/140) | 1.09 | 0.00261 | 0.008149 |
GO:0016482 | cytosolic transport | 1.43% (2/140) | 4.6 | 0.003173 | 0.009808 |
GO:0044248 | cellular catabolic process | 4.29% (6/140) | 2.07 | 0.003328 | 0.010185 |
GO:0008150 | biological_process | 38.57% (54/140) | 0.47 | 0.003774 | 0.011435 |
GO:0051128 | regulation of cellular component organization | 2.14% (3/140) | 3.17 | 0.004687 | 0.014063 |
GO:0005575 | cellular_component | 29.29% (41/140) | 0.55 | 0.005529 | 0.016425 |
GO:0016746 | acyltransferase activity | 4.29% (6/140) | 1.82 | 0.007456 | 0.021938 |
GO:0140767 | enzyme-substrate adaptor activity | 0.71% (1/140) | 6.9 | 0.008353 | 0.024114 |
GO:1990756 | ubiquitin ligase-substrate adaptor activity | 0.71% (1/140) | 6.9 | 0.008353 | 0.024114 |
GO:0044255 | cellular lipid metabolic process | 4.29% (6/140) | 1.76 | 0.009255 | 0.026467 |
GO:0006629 | lipid metabolic process | 5.0% (7/140) | 1.56 | 0.010167 | 0.028806 |
GO:0016651 | oxidoreductase activity, acting on NAD(P)H | 1.43% (2/140) | 3.48 | 0.014231 | 0.039951 |
GO:0006996 | organelle organization | 4.29% (6/140) | 1.6 | 0.015025 | 0.041796 |
GO:0006082 | organic acid metabolic process | 4.29% (6/140) | 1.55 | 0.017417 | 0.046751 |
GO:0043436 | oxoacid metabolic process | 4.29% (6/140) | 1.55 | 0.017356 | 0.047001 |
GO:0019752 | carboxylic acid metabolic process | 4.29% (6/140) | 1.56 | 0.017141 | 0.047253 |
GO:0016491 | oxidoreductase activity | 6.43% (9/140) | 1.2 | 0.017306 | 0.047281 |
GO:0016197 | endosomal transport | 1.43% (2/140) | 3.28 | 0.018317 | 0.04874 |
GO:0065008 | regulation of biological quality | 2.14% (3/140) | 2.43 | 0.018854 | 0.049737 |